Canopy Growth announces changes to Canadian operations
Production sites impacted represent 100% of its Canadian outdoor production.
Canopy Growth faces gross margin pressures, will limit spending: CFO
Pandemic is causing the cannabis company to lose some economies of scale.
Cannabis newcomer to start growing at massive Quebec facility
About 58,000 square metres, more than three times the size of the Montreal Canadiens’ Bell Centre arena.
Canopy Growth teams up with Drake on new cannabis venture
He’ll hold a 60% stake in More Life and Canopy Growth will own the remaining 40%.
Canopy Growth expands its pan-European cannabis network
Firm’s pharmaceutical business, Spectrum Therapeutics, has made strides in the UK and Luxembourg.
Canopy Growth buys ex NHL player’s sports nutrition business
Mike Cammalleri’s BioSteel is now developing a line of cannabidiol products.
Canopy Growth buys German medical cannabis company for $343M
C3 Cannabinoid Compound Co. has two manufacturing facilities specializing in natural extraction and synthetic cannabinoid production.
Canopy Growth acquires hemp company AgriNextUSA in a move to boost US business
The Ontario-based company has announced plans to invest between US$100 million and US$150 million at its proposed New York hemp operations.
Martha Stewart to work with Canopy Growth in developing hemp-based products
Canopy Growth says it will use Stewart’s knowledge of consumer products.
Pot-based medical pet products closer to fruition as research grows
Canopy Growth embarking on a Health Canada-approved clinical trial using cannabis-based products to treat animal anxiety.
